Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Non-Small-Cell Lung × Cobicistat × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1 BRAF V600E Mutation 1

Interventions

pembrolizumab 111 Carboplatin 101 Pemetrexed 86 Cisplatin 57 Paclitaxel 44 Nivolumab 34 Drug Therapy 34 osimertinib 33 Docetaxel 31 Specimen Handling 29 Magnetic Resonance Spectroscopy 25 Bevacizumab 24 durvalumab 19 Radiotherapy 19 tislelizumab 18 cemiplimab 18 130-nm albumin-bound paclitaxel 18 Gemcitabine 16 atezolizumab 15 Radiosurgery 15 Immunotherapy 14 aflutinib 13 Ipilimumab 13 Cetuximab 12 Platinum Compounds 11 Immune Checkpoint Inhibitors 11 Surgical Procedures, Operative 10 Standard of Care 10 Blood Specimen Collection 10 Biopsy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05748093 2024-08-09

OSIBOOST 2

Maastricht University Medical Center

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡